Literature DB >> 33457377

Critical Care COVID-19 Patient with a Picture of Thrombotic Thrombocytopenic Purpura.

Rehab Y Al-Ansari1, Mohanad Bakkar2, Leena Abdalla2, Khaled Sewify3.   

Abstract

BACKGROUND: Thrombotic thrombocytopenic purpura (TTP) is an uncommon haematological disease which can occur at any age and may present with COVID-19. This case describes a COVID-19 complication associated with a presentation resembling TTP. CASE DESCRIPTION: A 51-year-old man who had received a kidney transplant and was on immunosuppressant medication, was admitted to a critical care unit with severe COVID-19 pneumonia/acute respiratory distress syndrome (ARDS) which required intubation, mechanical ventilation and inotropic support. The course was complicated by the classic pentad of thrombocytopenia, intravascular haemolysis, acute kidney injury, neurological symptoms and fever, which prompted the diagnosis of probable TTP. After five sessions of therapeutic plasma exchange, the patient's general status improved, he was weaned off mechanical ventilation and his renal panel and haemolytic markers normalized.
CONCLUSION: TTP is a life-threatening condition which requires urgent management with therapeutic plasma exchange. This case highlights some possible complications of COVID-19 generally and in immunocompromised patients specifically. The potential role of plasma exchange in COVID-19 patients without a positive diagnosis of TTP (the so-called 'TTP resembling presentation') is an area of further research. LEARNING POINTS: COVID-19 can manifest as a picture of thrombotic thrombocytopenic purpura (TTP) which requires therapeutic plasma exchange as in other cases of TTP.Further research is required on the use of therapeutic plasma exchange in severe COVID-19 with cytokine storm. © EFIM 2020.

Entities:  

Keywords:  COVID-19; Thrombotic thrombocytopenic purpura; cytokine storm; plasma exchange

Year:  2020        PMID: 33457377      PMCID: PMC7806298          DOI: 10.12890/2020_002143

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  9 in total

Review 1.  Thrombotic thrombocytopenic purpura.

Authors:  Bérangère S Joly; Paul Coppo; Agnès Veyradier
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

2.  von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

Authors:  M Furlan; R Robles; M Galbusera; G Remuzzi; P A Kyrle; B Brenner; M Krause; I Scharrer; V Aumann; U Mittler; M Solenthaler; B Lämmle
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

3.  Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case.

Authors:  Fehmi Hindilerden; Ipek Yonal-Hindilerden; Emre Akar; Kadriye Kart-Yasar
Journal:  Thromb Res       Date:  2020-07-05       Impact factor: 3.944

4.  Therapeutic plasma exchange in adults with severe COVID-19 infection.

Authors:  Faryal Khamis; Ibrahim Al-Zakwani; Sabria Al Hashmi; Samata Al Dowaiki; Maher Al Bahrani; Nenad Pandak; Huda Al Khalili; Ziad Memish
Journal:  Int J Infect Dis       Date:  2020-06-23       Impact factor: 3.623

Review 5.  The cytokine storm and COVID-19.

Authors:  Biying Hu; Shaoying Huang; Lianghong Yin
Journal:  J Med Virol       Date:  2020-09-30       Impact factor: 20.693

6.  Efficacy of therapeutic plasma exchange in severe COVID-19 patients.

Authors:  Li Zhang; Hui Zhai; Shasha Ma; Jiasheng Chen; Yu Gao
Journal:  Br J Haematol       Date:  2020-06-12       Impact factor: 8.615

Review 7.  Mechanism of thrombocytopenia in COVID-19 patients.

Authors:  Panyang Xu; Qi Zhou; Jiancheng Xu
Journal:  Ann Hematol       Date:  2020-04-15       Impact factor: 3.673

8.  COVID-19-associated immune thrombocytopenia.

Authors:  Gienke Bomhof; Pim G N J Mutsaers; Frank W G Leebeek; Peter A W Te Boekhorst; Johannes Hofland; F Nanne Croles; A J Gerard Jansen
Journal:  Br J Haematol       Date:  2020-06-08       Impact factor: 8.615

Review 9.  Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura.

Authors:  Ashley Hanlon; Ara Metjian
Journal:  Ther Adv Hematol       Date:  2020-02-07
  9 in total
  2 in total

1.  Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection.

Authors:  Fei Fang; Brandon Tse; Katerina Pavenski
Journal:  BMJ Case Rep       Date:  2022-07-28

Review 2.  Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: Literature Review.

Authors:  Marija Malgaj Vrečko; Andreja Aleš Rigler; Željka Večerić-Haler
Journal:  Int J Mol Sci       Date:  2022-09-25       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.